Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer's disease continuum
- DOI
- 10.1002/dad2.70417
- Published
- 2026-06-30
- Container
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/dad2.70417,
title = {Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer's disease continuum},
author = {Patrizia Pignataro and Manuela Dicarlo and Daniele Urso and Chiara Zecca and Graziana Colaianni and Maria Teresa Dell'Abate and Davide Vilella and Francesco Borlizzi and Clelia Suriano and Angela Oranger and Silvia Colucci and Maria Grano and Giancarlo Logroscino},
year = {2026},
journal = {Alzheimer's \& Dementia: Diagnosis, Assessment \& Disease Monitoring},
doi = {10.1002/dad2.70417},
url = {https://doi.org/10.1002/dad2.70417}
}RIS
TY - JOUR TI - Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer's disease continuum AU - Patrizia Pignataro AU - Manuela Dicarlo AU - Daniele Urso AU - Chiara Zecca AU - Graziana Colaianni AU - Maria Teresa Dell'Abate AU - Davide Vilella AU - Francesco Borlizzi AU - Clelia Suriano AU - Angela Oranger AU - Silvia Colucci AU - Maria Grano AU - Giancarlo Logroscino PY - 2026 JO - Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring DO - 10.1002/dad2.70417 UR - https://doi.org/10.1002/dad2.70417 ER -
APA
Pignataro, P., Dicarlo, M., Urso, D., Zecca, C., Colaianni, G., Dell'Abate, M. T., Vilella, D., Borlizzi, F., Suriano, C., Oranger, A., Colucci, S., Grano, M., & Logroscino, G. (2026). Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer's disease continuum. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1002/dad2.70417
Source records
- crossref · retrieved 2026-09-26T03:38:04.211Z